New Drug Approved for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 240
usnews Jul 4, 2024 0 237
usnews Jul 4, 2024 0 237
usnews Jul 4, 2024 0 233
usnews Jul 4, 2024 0 231